Shan Ahmed Khan

Shan Ahmed Khan is a senior markets reporter at TS2.tech, specializing in stocks, technology and macroeconomic trends. A graduate of the Lahore University of Management Sciences (LUMS), he previously worked in investment research and market analysis. His coverage helps readers understand the key developments influencing global financial markets and emerging industries.

BP Q4 2025 results: BP halts buybacks after $4bn write-downs and a $1.5bn U.S. asset deal

BP Q4 2025 results: BP halts buybacks after $4bn write-downs and a $1.5bn U.S. asset deal

BP hit the brakes on its share buyback program Tuesday, opting instead to channel extra cash toward trimming debt and boosting oil-and-gas spending, after quarterly underlying profit numbers landed largely in line with forecasts. The company also flagged roughly $4.2 billion in impairments and disclosed it had unloaded a minority stake in its U.S. onshore oil assets for $1.5 billion.
China’s Arexvy review puts GSK stock back in focus before London trade

China’s Arexvy review puts GSK stock back in focus before London trade

GSK plc shares are set to trade with new vaccine developments on the radar. The company reported that China’s Center for Drug Evaluation has taken up its application for Arexvy, the RSV shot designed for people 60 and up. GSK noted that, should approval come through, Arexvy would mark the first vaccine in China targeting RSV-linked lower respiratory tract disease in that demographic.
1 56 57 58 59 60 607

Stock Market Today

  • MKC, PEBO Directors Boost Stakes in Latest Insider Buys
    July 27, 2026, 2:38 PM EDT. On Thursday, McCormick Director Michael Aaron Conway acquired 1,100 MKC shares at $50.21 apiece, spending $55,227, as MKC traded 1.9% higher Monday. At Peoples Bancorp, Director Dwight Eric Smith picked up 1,000 shares for $39.81 each, amounting to $39,810, with PEBO rising 0.7% during the session. These recent insider transactions highlight confidence from company directors.